Top
OR2M3 has not been detected as a mutational cancer driver

OR2M3
Ensembl id ENSG00000228198
Mutated samples
Coding Sequence 101 (1.5%)
Protein Affecting 84 (1.2%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all OR2M3 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 34 25 6.78
Lung adenocarcinoma No 19 16 4.09
Lung squamous cell carcinoma No 9 7 4.02
Head and neck squamous cell carcinoma No 9 7 1.87
Small cell lung carcinoma No 5 5 7.25
Uterine corpus endometrioid carcinoma No 4 4 1.74
Stomach adenocarcinoma No 4 4 2.48
Prostate adenocarcinoma No 3 3 1.23
Thyroid carcinoma No 3 3 0.93
Glioblastoma multiforme No 3 3 0.79
Esophageal carcinoma No 2 2 1.37
Bladder carcinoma No 1 1 1.02
Acute myeloid leukemia No 1 1 0.51
Lower grade glioma No 1 1 0.59
Serous ovarian adenocarcinoma No 1 1 0.32
Diffuse B cell lymphoma No 1 1 4.35
Chronic lymphocytic leukemia No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence